Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenoma benign | x | x | x | x | x | x | x | ||||
| Anaphylactic shock | x | ||||||||||
| Arthritis | x | x | x | x | x | ||||||
| Duodenal ulcer | x | x | x | x | x | x | x | x | |||
| Dyspepsia | x | ||||||||||
| Erosive oesophagitis | x | x | x | x | x | ||||||
| Functional dyspepsia | x | ||||||||||
| Gastric ulcer | x | x | x | x | x | x | x | x | x | ||
| Gastrinoma | x | x | |||||||||
| Gastrooesophageal reflux disease | x | x | x | x | x | x | x | x | |||
| Haemorrhage | x | ||||||||||
| Heartburn | x | x | |||||||||
| Hyperchlorhydria | x | ||||||||||
| Pain | x | x | x | x | x | x | x | ||||
| Peptic ulcer | x | ||||||||||
| Scleroderma | x | x | |||||||||
| Stress ulcer | x | ||||||||||
| Systemic mastocytosis | x | x | x | x | x | x | x | ||||
| Ulcer | x | x | x | x | x | x | x | ||||
| Upper gastrointestinal haemorrhage | x | ||||||||||
| Zollinger-Ellison syndrome | x | x | x | x | x | x | x | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |